Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received two suspension orders from the Drugs Control Administration, Karnataka. The orders pertain to a store at Indiranagar Chikodi (suspended for 2 days) and a store at PPC College Road Udupi (suspended for 3 days). The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940. Orders were received on April 24, 2025. The company has estimated a potential revenue loss of approximately Rs. 0.49 lakhs and Rs. 0.42 lakhs for the two stores respectively.
The financial impact is negligible for shareholders, with combined potential revenue loss of less than Rs. 1 lakh from two small stores. No material effect on overall operations is expected, though repeated license suspensions at subsidiary stores could attract regulatory scrutiny if they continue.